Document Detail

Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease.
MedLine Citation:
PMID:  20030528     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate antiproteinuric effect of spironolactone in patients with chronic kidney disease (CKD) treated with angiotensin-converting enzyme (ACE) inhibitors and/or angiotensin II type 1 receptor blockers (ARBs). METHODS: This study was performed in 33 CKD patients with proteinuria. 24 h urinary protein excretion and biochemical parameters were obtained before the therapy. Then, spironolactone (25 mg/d) was added to the therapy. The antiproteinuric effect of spironolactone was examined for eight weeks. RESULTS: At eight weeks, there was a significant decrease in proteinuria (p < 0.001, 47.9% decrease). Systolic and diastolic blood pressures were significantly decreased (p < 0.004, p < 0.001, respectively). However, no correlation was detected between the reductions in systolic and diastolic BP and the reduction in proteinuria (p = 0.464, p = 0.239, respectively). Serum potassium level increased significantly (p < 0.001). CONCLUSIONS: Our study suggests that spironolactone significantly reduces urinary protein excretion. This strategy may be useful to slow the progression of CKD. However, hyperkalemia is the most important side effect of treatment, and it is necessary to monitor potassium level. Further studies are needed to determine the efficacy of spironolactone on proteinuria.
Erkan Sengul; Tayfun Sahin; Erce Sevin; Ahmet Yilmaz
Related Documents :
11847548 - Postprandial hemodynamic changes in hypertensives treated with calcium antagonists or a...
3530558 - Long-term treatment with captopril in pediatric patients with severe hypertension and c...
16830788 - The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide conta...
3028438 - Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramip...
22668978 - The effect of selective laser trabeculoplasty on aqueous humor dynamics in patients wit...
15147658 - Echocardiographic assessment of left ventricular midwall mechanics in spontaneously hyp...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Renal failure     Volume:  31     ISSN:  1525-6049     ISO Abbreviation:  Ren Fail     Publication Date:  2009  
Date Detail:
Created Date:  2009-12-24     Completed Date:  2010-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701128     Medline TA:  Ren Fail     Country:  England    
Other Details:
Languages:  eng     Pagination:  928-32     Citation Subset:  IM    
Department of Nephrology, Faculty of Medicine, University of Kocaeli, Kocaeli, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone Antagonists / therapeutic use*
Middle Aged
Prospective Studies
Proteinuria / drug therapy*,  etiology
Renal Insufficiency, Chronic / complications*
Spironolactone / therapeutic use*
Reg. No./Substance:
0/Aldosterone Antagonists; 52-01-7/Spironolactone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence of chronic kidney disease in the black sea region, Turkey, and investigation of the relat...
Next Document:  Factors related to silent myocardial damage in hemodialysis patients.